BUDECIP-0.5 MG

Product Overview

BUDECIP-0.5 MG is a premium-quality Budesonide Inhalation Suspension marketed by Veasley Pharmaceuticals Pvt Ltd. It is commonly prescribed for the maintenance and preventive treatment of asthma, COPD, and other inflammatory respiratory conditions. The formulation helps reduce airway inflammation, improves lung function, and supports long-term respiratory control.

Composition

• Budesonide IP – 0.5 mg

Therapeutic Uses / Indications

• Bronchial Asthma

• Chronic Obstructive Pulmonary Disease (COPD)

• Wheezing and airway inflammation

• Prevention of asthma attacks

• Other corticosteroid-responsive respiratory disorders

Key Benefits of BUDECIP-0.5 MG

• Effective anti-inflammatory corticosteroid

• Helps reduce swelling and mucus in airways

• Improves breathing and respiratory comfort

• Suitable for pediatric and adult patients (as prescribed)

• Safe for long-term maintenance therapy

• Consistent quality with reliable clinical outcomes

Why Choose BUDECIP-0.5 MG from Veasley Pharmaceuticals?

• Manufactured in WHO-GMP certified facilities

• Trusted and well-established respiratory molecule

• Competitive pricing for PCD Pharma Franchise partners

• High demand product in pulmonology segment

• Strong support for marketing and distribution

Dosage & Administration

Use as directed by the physician. Dosage depends on patient age, severity of disease, and clinical response.
For inhalation use only.

Storage Instructions

• Store below 25°C in a dry place

• Protect from light and moisture

• Keep out of reach of children

Safety Information

• Prescription medicine only

• Do not exceed recommended dose

• Rinse mouth after use to reduce risk of oral irritation